Epithelioid Hemangioendothelioma (EHE)
3 clinical trials · Condition
◉ Watch Epithelioid Hemangioendothelioma (EHE)
| Record | Firm | Date |
|---|---|---|
| SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma (NCT07104331) | Sarcoma Alliance for Research through Collaboration | 2026-02-24 |
| A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors (NCT06452160) | BridGene Biosciences Inc. | 2024-06-27 |
| Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors (NCT05228015) | Ikena Oncology | 2022-01-07 |
Track Epithelioid Hemangioendothelioma (EHE) automatically
Every clearance here is in the API, with alerts when new ones post.